• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

莪术醇,一种新型植物源 5α-还原酶抑制剂,治疗男性型秃发:一项多中心、随机、双盲、安慰剂对照研究。

Curcuma aeruginosa, a novel botanically derived 5α-reductase inhibitor in the treatment of male-pattern baldness: a multicenter, randomized, double-blind, placebo-controlled study.

机构信息

Cosmetic and Natural Product Research Center, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, Thailand.

出版信息

J Dermatolog Treat. 2012 Oct;23(5):385-92. doi: 10.3109/09546634.2011.568470. Epub 2011 Jul 14.

DOI:10.3109/09546634.2011.568470
PMID:21756154
Abstract

BACKGROUND

Several botanically derived agents are available for the treatment of male-pattern baldness.

OBJECTIVE

The aim of this study was to evaluate the efficacy of 5% hexane extract of Curcuma aeruginosa, a botanically derived inhibitor of 5α-reductase and 5% minoxidil in the treatment of androgenetic alopecia.

METHODS

Eighty-seven men with androgenetic alopecia (AGA) were randomized to receive 5% Curcuma aeruginosa, 5% minoxidil, combination formulation (5% hexane extract of Curcuma aeruginosa + 5% minoxidil) or placebo, twice daily for 6 months. Efficacy was assessed by target area hair count, global photographic review as well as patients' subjective assessments of hair regrowth and hair shedding.

RESULTS

There were statistically significant improvements in global photographic review (p < 0.001), subjects' overall assessments of hair regrowth (p = 0.008), and hair shedding (p = 0.004) when the combination formulation was compared with placebo. Similarly, treatment with 5% minoxidil and 5% C. aeruginosa extract also led to some degrees of hair regrowth. There were no serious adverse events during and after the study.

CONCLUSION

In men with hair loss in the vertex area of the scalp, the combination of 5% hexane extract of C. aeruginosa and 5% minoxidil slowed hair loss and increased hair growth.

摘要

背景

有几种植物衍生剂可用于治疗男性型秃发。

目的

本研究旨在评估 5%莪术己烷提取物(一种植物源性 5α-还原酶抑制剂)和 5%米诺地尔治疗雄激素性脱发的疗效。

方法

87 例男性雄激素性脱发患者随机分为 5%莪术、5%米诺地尔、联合制剂(5%莪术己烷提取物+5%米诺地尔)或安慰剂组,每天两次,疗程 6 个月。通过靶区毛发计数、全球照片评估以及患者对头发再生和脱发的主观评估来评估疗效。

结果

与安慰剂相比,联合制剂在全球照片评估(p<0.001)、患者对头发再生的总体评估(p=0.008)和脱发(p=0.004)方面均有统计学显著改善。同样,5%米诺地尔和 5%莪术提取物的治疗也导致了一定程度的头发再生。研究期间和研究结束后均无严重不良事件。

结论

在头皮顶点脱发的男性中,5%莪术己烷提取物和 5%米诺地尔的联合应用可减缓脱发并促进头发生长。

相似文献

1
Curcuma aeruginosa, a novel botanically derived 5α-reductase inhibitor in the treatment of male-pattern baldness: a multicenter, randomized, double-blind, placebo-controlled study.莪术醇,一种新型植物源 5α-还原酶抑制剂,治疗男性型秃发:一项多中心、随机、双盲、安慰剂对照研究。
J Dermatolog Treat. 2012 Oct;23(5):385-92. doi: 10.3109/09546634.2011.568470. Epub 2011 Jul 14.
2
A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women.一项针对女性雄激素性脱发的 5%米诺地尔泡沫每日一次与 2%米诺地尔溶液每日两次治疗的随机、单盲试验。
J Am Acad Dermatol. 2011 Dec;65(6):1126-1134.e2. doi: 10.1016/j.jaad.2010.09.724. Epub 2011 Jun 23.
3
A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss.一项关于5%和2%外用米诺地尔溶液治疗女性型脱发的随机、安慰剂对照试验。
J Am Acad Dermatol. 2004 Apr;50(4):541-53. doi: 10.1016/j.jaad.2003.06.014.
4
Efficacy and safety of 3% minoxidil versus combined 3% minoxidil / 0.1% finasteride in male pattern hair loss: a randomized, double-blind, comparative study.3%米诺地尔与3%米诺地尔/0.1%非那雄胺联合治疗男性型脱发的疗效与安全性:一项随机、双盲、对照研究
J Med Assoc Thai. 2012 Oct;95(10):1312-6.
5
A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.一项关于0.25%非那雄胺与3%米诺地尔混合外用溶液对比3%米诺地尔溶液治疗男性雄激素性脱发疗效和安全性的随机双盲对照研究。
J Eur Acad Dermatol Venereol. 2018 Dec;32(12):2257-2263. doi: 10.1111/jdv.15171. Epub 2018 Jul 20.
6
A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men.一项多中心、随机、安慰剂对照、双盲临床试验,比较5%米诺地尔新型外用泡沫制剂与安慰剂治疗男性雄激素性脱发的疗效。
J Am Acad Dermatol. 2007 Nov;57(5):767-74. doi: 10.1016/j.jaad.2007.04.012. Epub 2007 Aug 29.
7
A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia.一项多中心、随机、阳性药物对照、双盲临床试验,旨在评估不同剂量度他雄胺治疗男性雄激素性脱发的有效性和安全性。
J Am Acad Dermatol. 2014 Mar;70(3):489-498.e3. doi: 10.1016/j.jaad.2013.10.049. Epub 2014 Jan 9.
8
Topical fulvestrant solution has no effect on male and postmenopausal female androgenetic alopecia: results from two randomized, proof-of-concept studies.局部用氟维司群溶液对男性和绝经后女性雄激素性脱发无效:两项随机概念验证研究的结果
Br J Dermatol. 2008 Jan;158(1):109-15. doi: 10.1111/j.1365-2133.2007.08276.x. Epub 2007 Nov 6.
9
A Single-Centre, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Investigate the Efficacy and Safety of Minoxidil Topical Foam in Frontotemporal and Vertex Androgenetic Alopecia in Men.一项单中心、随机、双盲、安慰剂对照临床试验,旨在研究米诺地尔外用泡沫治疗男性额颞部及头顶雄激素性脱发的疗效和安全性。
Skin Pharmacol Physiol. 2015;28(5):236-44. doi: 10.1159/000375320. Epub 2015 Mar 3.
10
Treatment of female pattern hair loss with a combination of spironolactone and minoxidil.螺内酯与米诺地尔联合治疗女性型脱发
Australas J Dermatol. 2007 Feb;48(1):43-5. doi: 10.1111/j.1440-0960.2007.00332.x.

引用本文的文献

1
Effectiveness and Safety of Hair Growth Formulation Containing L.f (Teak) Leaf Extract: A Randomized, Double-Blind, Placebo-Controlled Study on Males with Androgenic Alopecia.含 L.f(柚木)叶提取物的生发配方的有效性和安全性:一项针对男性雄激素性脱发的随机、双盲、安慰剂对照研究。
J Evid Based Integr Med. 2024 Jan-Dec;29:2515690X241291141. doi: 10.1177/2515690X241291141.
2
Network Pharmacology Reveals Roxb. Regulates MAPK and HIF-1 Pathways to Treat Androgenetic Alopecia.网络药理学揭示了刺蒺藜调节丝裂原活化蛋白激酶(MAPK)和缺氧诱导因子-1(HIF-1)信号通路以治疗雄激素性脱发。
Biology (Basel). 2024 Jul 4;13(7):497. doi: 10.3390/biology13070497.
3
Prioritizing susceptibility genes for the prognosis of male-pattern baldness with transcriptome-wide association study.
基于转录组全基因组关联研究优先考虑男性型秃发的易感性基因。
Hum Genomics. 2024 Apr 2;18(1):34. doi: 10.1186/s40246-024-00591-y.
4
Relative Effects of Minoxidil 5%, Platelet-Rich Plasma, and Microneedling in Pattern Hair Loss: A Systematic Review and Network Meta-Analysis.5%米诺地尔、富血小板血浆和微针治疗对雄激素性脱发的相对疗效:一项系统评价和网状Meta分析
Skin Appendage Disord. 2023 Dec;9(6):397-406. doi: 10.1159/000534196. Epub 2023 Oct 27.
5
Hair regrowth treatment efficacy and resistance in androgenetic alopecia: A systematic review and continuous Bayesian network meta-analysis.雄激素性脱发的毛发再生治疗疗效与抗性:一项系统评价与连续贝叶斯网络荟萃分析
Front Med (Lausanne). 2023 Jan 23;9:998623. doi: 10.3389/fmed.2022.998623. eCollection 2022.
6
A Multimodal Hair-Loss Treatment Strategy Using a New Topical Phytoactive Formulation: A Report of Five Cases.一种使用新型局部植物活性制剂的多模式脱发治疗策略:五例报告。
Case Rep Dermatol Med. 2021 Feb 4;2021:6659943. doi: 10.1155/2021/6659943. eCollection 2021.
7
The Potential Role of Nutraceuticals as an Adjuvant in Breast Cancer Patients to Prevent Hair Loss Induced by Endocrine Therapy.营养保健品作为乳腺癌患者内分泌治疗脱发的辅助治疗手段的潜力。
Nutrients. 2020 Nov 18;12(11):3537. doi: 10.3390/nu12113537.
8
Complementary and Alternative Treatments for Alopecia: A Comprehensive Review.斑秃的补充和替代疗法:全面综述
Skin Appendage Disord. 2019 Feb;5(2):72-89. doi: 10.1159/000492035. Epub 2018 Aug 21.
9
Efficacy of Off-Label Topical Treatments for the Management of Androgenetic Alopecia: A Review.非标签外用治疗雄激素性脱发的疗效:综述。
Clin Drug Investig. 2019 Mar;39(3):233-239. doi: 10.1007/s40261-018-00743-8.
10
Chemical Composition and Biological Activities of Essential Oils of Species.植物种属精油的化学组成与生物活性。
Nutrients. 2018 Sep 1;10(9):1196. doi: 10.3390/nu10091196.